Literature DB >> 10455963

Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts.

S Takaya1, A Jain, A Yagihashi, K Nakamura, M Kobayashi, K Takeuchi, S Suzuki, Y Iwaki, A J Demetris, S Todo, J J Fung, T E Starzl.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10455963      PMCID： PMC2980294          DOI： 10.1016/s0041-1345(99)00256-0

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  17 in total

1.  Liver transplantation in positive cytotoxic crossmatch cases using FK506, high-dose steroids, and prostaglandin E1.

Authors:  S Takaya; Y Iwaki; T E Starzl
Journal:  Transplantation       Date:  1992-11       Impact factor: 4.939

2.  Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys.

Authors:  Thomas E Starzl; Anthony J Demetris; Satoru Todo; Yoogoo Kang; Andreas Tzakis; Rene Duquesnoy; Leonard Makowka; Barbara Banner; Waldo Concepcion; Kendrick A Porter
Journal:  Clin Transplant       Date:  1989       Impact factor: 2.863

3.  The impact of a positive crossmatch upon outcome after liver transplantation.

Authors:  W C Goggins; R A Fisher; P M Kimball; L Wolfe; B E Hill; T D Pietruszka; M L Shiffman; A J Sanyal; V A Luketic; J M Ham; M P Posner
Journal:  Transplantation       Date:  1996-12-27       Impact factor: 4.939

4.  The association of antivascular endothelial cell antibody with hyperacute rejection: a case report.

Authors:  L Brasile; E Rodman; C F Shield; J Clarke; J Cerilli
Journal:  Surgery       Date:  1986-05       Impact factor: 3.982

5.  Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts.

Authors:  K P Batts; S B Moore; J D Perkins; R H Wiesner; P M Grambsch; R A Krom
Journal:  Transplantation       Date:  1988-02       Impact factor: 4.939

6.  Increased bile duct complications in liver transplantation across the ABO barrier.

Authors:  L Sanchez-Urdazpal; K P Batts; G J Gores; S B Moore; S Sterioff; R H Wiesner; R A Krom
Journal:  Ann Surg       Date:  1993-08       Impact factor: 12.969

7.  HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching.

Authors:  A Nikaein; L Backman; L Jennings; M F Levy; R Goldstein; T Gonwa; M J Stone; G Klintmalm
Journal:  Transplantation       Date:  1994-10-15       Impact factor: 4.939

8.  A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors.

Authors:  S Oguma; S Belle; T E Starzl; A J Demetris
Journal:  Hepatology       Date:  1989-02       Impact factor: 17.425

9.  Biliary strictures complicating liver transplantation. Incidence, pathogenesis, management, and outcome.

Authors:  J O Colonna; A Shaked; A S Gomes; S D Colquhoun; O Jurim; S V McDiarmid; J M Millis; L I Goldstein; R W Busuttil
Journal:  Ann Surg       Date:  1992-09       Impact factor: 12.969

10.  Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group.

Authors: 
Journal:  Lancet       Date:  1994-08-13       Impact factor: 79.321
View more
  2 in total

Review 1.  Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation.

Authors:  Arno Kornberg
Journal:  World J Hepatol       Date:  2015-06-18

2.  Donor-Specific Antibodies Against Donor Human Leukocyte Antigen are Associated with Graft Inflammation but Not with Fibrosis Long-Term After Liver Transplantation: An Analysis of Protocol Biopsies.

Authors:  Safak Gül-Klein; Henriette Hegermann; Robert Röhle; Moritz Schmelzle; Frank Tacke; Wenzel Schöning; Robert Öllinger; Tomasz Dziodzio; Patrick Maier; Julius M Plewe; David Horst; Igor Maximilian Sauer; Johann Pratschke; Nils Lachmann; Dennis Eurich
Journal:  J Inflamm Res       Date:  2021-06-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.